Related Experiment Videos

Alteration of chromatin structure induced by the binding of adriamycin, daunorubicin and ethidium bromide

Biochemical Pharmacology
|November 1, 1982
PubMed

Insights

Adriamycin, daunorubicin, and ethidium bromide alter chromatin structure by causing unfolding and disrupting core particles. Daunorubicin showed the most significant impact on DNA organization.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Genetics

Background:

  • Chromatin, the complex of DNA and proteins, dictates DNA accessibility and gene regulation.
  • Intercalating agents and DNA-binding drugs can alter DNA and chromatin structure.
  • Understanding drug-induced structural changes is crucial for pharmacology and molecular biology.

Purpose of the Study:

  • To investigate the structural modifications in chromatin induced by adriamycin (ADR), daunorubicin (DR), and ethidium bromide (EtdBr).
  • To compare the effects of these three drugs on DNA organization within isolated chromatin, nuclei, and whole cells.

Main Methods:

  • Chromatin structural analysis using micrococcal nuclease as a probe.
  • Treatment of isolated chromatin, nuclei, and whole cells with ADR, DR, and EtdBr.
  • Quantification of acid-soluble oligonucleotides and subnucleosomal DNA fragments to assess structural changes.

Main Results:

  • Drug binding induced chromatin unfolding, evidenced by increased acid-soluble oligonucleotides.
  • Core particle structure disruption occurred, leading to subnucleosomal DNA fragments and altered nucleosome patterns.
  • Daunorubicin exhibited the most potent effects, followed by adriamycin, and then ethidium bromide.

Conclusions:

  • Adriamycin, daunorubicin, and ethidium bromide significantly alter chromatin higher-order structure.
  • The drugs cause both global chromatin unfolding and specific disruption of nucleosome core particles.
  • Drug-induced structural changes vary in magnitude, with daunorubicin being the most disruptive.

Related Concept Videos